News
A new type of MRI scan detects how quickly someone is ageing and how likely they are to develop dementia long before symptoms ...
9d
News-Medical.Net on MSNHeavy smoking linked to atrophy in Alzheimer’s brain regionsMRI findings indicate that smoking is linked to reduced brain volume, raising concerns about dementia risk, especially with ...
Patients with breast cancer who undergo chemotherapy may face an increased risk for brain atrophy and cognitive decline, new ...
Is your brain aging faster than your chronological age? New research shows it could raise your risk of death and dementia ...
5d
Live Science on MSNDementia: Facts about Alzheimer's and other forms of dementiaDementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...
Investigators developed the Dunedin Pace of Aging Calculated from NeuroImaging (DunedinPACNI) to estimate an individual’s pace of aging based on brain MRI features such as cortical thickness ...
21d
Irish Star on MSNDementia isn't a normal part of ageing and lifestyle changes can slash your riskDementia is a common condition in the UK, affecting an estimated 944,000 people. While it's commonly assumed to be an inevitable aspect of growing older, it is possible to take steps to reduce your ...
Scientists have developed a groundbreaking tool that can measure how fast a person is aging and predict their future risk of chronic diseases like dementia using a single brain MRI scan.
MRI (magnetic resonance imaging) is an incredible technique that was first used to scan patients in the 1970s and 1980s. It uses radio waves, giant magnets, and computational tools to visualize ...
For this study, researchers focused on 270 individuals who had both sleep and brain imaging data available and who had no signs of stroke or dementia at the time of the sleep assessment. The team ...
"Higher levels of leptin indicate brain protection against late-life dementia." ScienceDaily. ScienceDaily, 18 September 2024. <www.sciencedaily.com / releases / 2024 / 09 / 240918142424.htm>.
Satizabal is lead author of the study titled, "Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age," published Aug. 12 in Alzheimer's & Dementia: The Journal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results